Dihydrotestosterone alters cyclooxygenase-2 levels in human coronary artery smooth muscle cells
Authors:
- Rayna J. GonzalesRGRayna J. Gonzales
- Austin C. BoeseABAustin C. Boese
- Lin ChangLCLin Chang
- Ke-Jie YinKYKe-Jie Yin
- Y. Eugene ChenYCY. Eugene Chen
- Jean-Pyo LeeJLJean-Pyo Lee
- Milton H. HamblinMHMilton H. Hamblin
- Puneet RamanPRPuneet Raman
- Lakshmi MadhavpeddiLMLakshmi Madhavpeddi
- Rita C. TostesRTRita C. Tostes
- 1 April 2010
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 298 (4) , E838-E845
Abstract
Both protective and nonprotective effects of androgens on the cardiovascular system have been reported. Our previous studies show that the potent androgen receptor (AR) agonist dihydrotestosterone (DHT) increases levels of the vascular inflammatory mediator cyclooxygenase (COX)-2 in rodent cerebral arteries independent of an inflammatory stimulus. Little is known about the effects of androgens on inflammation in human vascular tissues. Therefore, we tested the hypothesis that DHT alters COX-2 levels in the absence and presence of induced inflammation in primary human coronary artery smooth muscle cells (HCASMC). Furthermore, we tested the ancillary hypothesis that DHT's effects on COX-2 levels are AR-dependent. Cells were treated with DHT (10 nM) or vehicle for 6 h in the presence or absence of LPS or IL-1β. Similar to previous observations in rodent arteries, in HCASMC, DHT alone increased COX-2 levels compared with vehicle. This effect of DHT was attenuated in the presence of the AR antagonist bicalutamide. Conversely, in the presence of LPS or IL-1β, increases in COX-2 were attenuated by cotreatment with DHT. Bicalutamide did not affect this response, suggesting that DHT-induced decreases in COX-2 levels occur independent of AR stimulation. Thus we conclude that DHT differentially influences COX-2 levels under physiological and pathophysiological conditions in HCASMC. This effect of DHT on COX-2 involves AR-dependent and- independent mechanisms, depending on the physiological state of the cell.Keywords
This publication has 40 references indexed in Scilit:
- Dose-Dependent Effects of Androgens on Outcome after Focal Cerebral Ischemia in Adult Male MiceJournal of Cerebral Blood Flow & Metabolism, 2009
- Heart Disease and Stroke Statistics—2009 UpdateCirculation, 2009
- Age-Dependent Effects of Testosterone in Experimental StrokeJournal of Cerebral Blood Flow & Metabolism, 2008
- Dihydrotestosterone Stimulates Cerebrovascular Inflammation through NFκB, Modulating Contractile FunctionJournal of Cerebral Blood Flow & Metabolism, 2008
- NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1αNature, 2008
- Deleterious Effects of Dihydrotestosterone on Cerebral Ischemic InjuryJournal of Cerebral Blood Flow & Metabolism, 2007
- The Janus Face of Cyclooxygenase-2 in Ischemic StrokeStroke, 2005
- Testosterone inhibits tumor necrosis factor‐α‐induced vascular cell adhesion molecule‐1 expression in human aortic endothelial cellsFEBS Letters, 2002
- Testosterone and coronary heart disease: is there a link?QJM: An International Journal of Medicine, 1997
- THE ROLE OF CYCLOOXYGENASE-2 IN INFLAMMATIONAmerican Journal of Therapeutics, 1995